The PE Ratio as of December 2025 (TTM) for Newron Pharmaceuticals S.p.A. (NWRN.SW) is 15.79

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current PE Ratio is 15.79. This represents a change of -112.83% compared to the average of -123.09 of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWRN.SW) Historical PE Ratio (quarterly & annually)

How has NWRN.SW PE Ratio performed in the past?

The mean historical PE Ratio of Newron Pharmaceuticals S.p.A. over the last ten years is -7.42. The current 15.79 PE Ratio has changed -21388.10% with respect to the historical average. Over the past ten years (40 quarters), NWRN.SW's PE Ratio was at its highest in in the June 2017 quarter at 49.13. The PE Ratio was at its lowest in in the June 2025 quarter at -487.07.

Newron Pharmaceuticals S.p.A. (NWRN.SW) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Newron Pharmaceuticals S.p.A. (NWRN.SW) Average PE Ratio

How has NWRN.SW PE Ratio performed in the past?

The current PE Ratio of Newron Pharmaceuticals S.p.A. (NWRN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Newron Pharmaceuticals S.p.A. (NWRN.SW) PE Ratio vs. Peers

How is NWRN.SW’s PE Ratio compared to its peers?

Newron Pharmaceuticals S.p.A.’s PE Ratio is less than COLTENE Holding AG (22.20), greater than DocMorris AG (-1.35), less than IVF Hartmann Holding AG (17.28), greater than Santhera Pharmaceuticals Holding AG (-2.42), greater than Molecular Partners AG (-1.93), greater than Relief Therapeutics Holding AG (-2.13), greater than Addex Therapeutics Ltd (-0.98), greater than Basilea Pharmaceutica AG (10.43), greater than EvoNext Holdings S.A. (-6.53), less than Ascom Holding AG (44.55),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.